Skip to main content

Table 10 Association of sub-clinical cardiotoxicity (EF changes ≥ 10%) with the cTnI changes six months after the completion of anthracycline chemotherapy

From: Electrocardiographic and biochemical analysis of anthracycline induced cardiotoxicity in breast cancer patients from Southern Sri Lanka

 

cTnI < 0.04 ng/mL

cTnI ≥ 0.04 ng/mL

EF difference (EF3-EF0) < 10%

98 (74.2%)

34 (25.8%)

EF difference (EF3-EF0) ≥ 10%

17 (26.6%)

47 (73.4%)

  1. n = 196, p-value = 0.001**
  2. cTnI cardiac troponin I, EF Ejection fraction
  3. p values *< 0.05, **< 0.01, ***< 0.001 considered as significant
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us